Glucagon
Drug Category | Drug | IHD Dosing | Administration Timing Around HD Session |
---|---|---|---|
Diabetes Medications | Glucagon | 0.25-2mg IV/IM once | Administer Anytime During HD |
Molecular Weight (Da) | Excreted Unchanged (%) | Normal Half-Life (Hours) | ESRD Half-Life (Hours) | Plasma Protein Binding (%) | Volume of Distribution (L/kg) | Dialytic Plasma Clearance (ml/min) | % Dialyzed |
---|---|---|---|---|---|---|---|
3483 | N/A | 0.17-0.75 | N/A | N/A | 0.25 | N/A | No (N/A) |
References:
- DrugBank [Online]. 2012 Apr 12 [cited 2012 May 6]; Available from: URL: http://www.drugbank.ca/drugs/DB00040
- Sherwin R, Bastl C, Finkelstein F, et al. Influence of Uremia and Hemodialysis on the Turnover and Metabolic Effects of Glucagon. Journal of Clinical Investigation. 1976;57(3):722-31.